Various proangiogenic factors that serve as potential biomarkers in cancer therapy are VEGF, bFGF, IL-8, PDGF, MMPs, endoglin, tissue factor, and hypoxia tissue factor [60–71] and among them, the important angiogenesis biomarkers explored for cancer therapy are discussed in the following subsection. This evidence concerns the gene ENG and cancer.